2 ML bupivacaine hydrochloride 7.5 MG/ML Injection
- RxCUI
- 1724784
- RxNorm name
- 2 ML bupivacaine hydrochloride 7.5 MG/ML Injection
- Display name
- BUPivacaine (Injectable)
- Full name
- 2 ML bupivacaine hydrochloride 7.5 MG/ML Injection
- Term type
- SCD
- Status
- Active
- Strength
- 7.5 mg/ml
- Dose form
- Injection 2 ml
- Route
- Injectable
- Updated
- 2026-10-27 17:48:53
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 012016
- Active start
- 012016
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| bupivacaine hydrochloride | 7.5 MG / 1 ML | bupivacaine | bupivacaine hydrochloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injection | 1649574 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| bupivacaine | 1815 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | 2 ML BUPivacaine hydrochloride 7.5 MG/ML Injection | 1 | NAMES |
| RxNorm Name | 2 ML bupivacaine hydrochloride 7.5 MG/ML Injection | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 5 | CODES | |
| RxCUI | 1724784 | 1 | CODES |
| MMSL_CODE | BD5593 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0264-9379-88 | 0264-9379 | Bupivacaine Hydrochloride with Dextrose Bupivacaine Hydrochloride with Dextrose | B. Braun Medical Inc. | ANDA209087 |
| 0409-3613-01 | 0409-3613 | Bupivacaine BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | Hospira, Inc. | ANDA071810 |
| 71351-022-10 | 71351-022 | Bupivacaine Hydrochloride Bupivacaine hydrochloride | Brookfield Pharmaceuticals, LLC. | ANDA212822 |
| 71351-022-50 | 71351-022 | Bupivacaine Hydrochloride Bupivacaine hydrochloride | Brookfield Pharmaceuticals, LLC. | ANDA212822 |
| 73293-0002-2 | 73293-0002 | Bupivacaine Hydrochloride Bupivacaine hydrochloride | Huons Co., Ltd. | ANDA212822 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA209087 | 0264-9379 | Bupivacaine Hydrochloride with Dextrose Bupivacaine Hydrochloride with Dextrose | ANDA | B. Braun Medical Inc. |
| ANDA071810 | 0409-3613 | Bupivacaine BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | ANDA | Hospira, Inc. |
| ANDA212822 | 71351-022 | Bupivacaine Hydrochloride Bupivacaine hydrochloride | ANDA | Brookfield Pharmaceuticals, LLC. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Marcaine Spinal | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | Hospira, Inc. | 9679cc05-2f8a-4e88-53b5-6e9122c8b8c0 | 2026-06-23 | Warnings, Adverse reactions | 00409176162 00409176102 1724784 |
| Bupivacaine Spinal | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | Hospira, Inc. | 7a8d2539-4422-4312-0298-207ef1a2948e | 2026-04-07 | Warnings, Adverse reactions | 0409-3613-01 0409-3613 00409361301 00409361311 1724784 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 02a845c3-4521-4926-e397-25ab536e7cf6 | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | 00409116501 00409116502 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Brookfield Pharmaceuticals, LLC. | e8b32972-6984-4f1c-e053-2995a90a3277 | 2026-01-13 | Warnings, Adverse reactions | 71351-022-10 71351-022-50 71351-022 71351002202 71351002210 71351002250 1724784 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Eugia US LLC | ffecf450-1f01-4721-8e10-251385852612 | 2025-05-29 | Boxed warning, Warnings, Adverse reactions | 55150017110 55150017230 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Huons Co., Ltd. | 2dc693df-3218-4a90-b3f7-21e80966a851 | 2024-11-20 | Warnings, Adverse reactions | 73293-0002-2 73293-0002 73293000201 73293000202 1724784 |
| Bupivacaine Hydrochloride with Dextrose | BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE | B. Braun Medical Inc. | ff43d2b6-acb4-45c8-96b6-971d2a7a6767 | 2024-11-05 | Warnings, Adverse reactions | 0264-9379-88 0264-9379 00264937988 1724784 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7a8d2539-4422-4312-0298-207ef1a2948e | BUPivacaine HCl 0.75 % in 2 ML Injection [PSN] · 2 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % per 2 ML Injection [SY] · bupivacaine HCl 15 MG per 2 ML Injection [SY] | 4 | 29 | These highlights do not include all the information needed to use BUPIVACAINE SPINAL safely and effectively. See full prescribing information for BUPIVACAINE SPINAL . BUPIVACAINE SPINAL (bupivacaine hydrochloride in dextrose injection) for subarachnoid injection Initial U.S. Approval: 1984 | 20260407 |
| 9679cc05-2f8a-4e88-53b5-6e9122c8b8c0 | BUPivacaine HCl 0.75 % in 2 ML Injection [PSN] · 2 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % per 2 ML Injection [SY] · bupivacaine HCl 15 MG per 2 ML Injection [SY] | 4 | 26 | These highlights do not include all the information needed to use MARCAINE ® SPINAL safely and effectively. See full prescribing information for MARCAINE ® SPINAL. MARCAINE ® SPINAL (bupivacaine hydrochloride in dextrose injection) for subarachnoid injection Initial U.S. Approval: 1984 | 20250513 |
| ff43d2b6-acb4-45c8-96b6-971d2a7a6767 | BUPivacaine HCl 0.75 % in 2 ML Injection [PSN] · 2 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % per 2 ML Injection [SY] · bupivacaine HCl 15 MG per 2 ML Injection [SY] | 4 | 11 | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION, USP safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION, USP. BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION, USP for subarachnoid injection Initial U.S. Approval: 1984 | 20241105 |
| 2dc693df-3218-4a90-b3f7-21e80966a851 | BUPivacaine HCl 0.75 % in 2 ML Injection [PSN] · 2 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % per 2 ML Injection [SY] · bupivacaine HCl 15 MG per 2 ML Injection [SY] | 4 | 10 | Bupivacaine Hydrochloride in Dextrose Injection, USP STERILE HYPERBARIC SOLUTION FOR SPINAL ANESTHESIA Rx only | 20241120 |
| e8b32972-6984-4f1c-e053-2995a90a3277 | BUPivacaine HCl 0.75 % in 2 ML Injection [PSN] · 2 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % per 2 ML Injection [SY] · bupivacaine HCl 15 MG per 2 ML Injection [SY] | 4 | 6 | Bupivacaine Hydrochloride in Dextrose Injection, USP STERILE HYPERBARIC SOLUTION FOR SPINAL ANESTHESIA Rx only | 20260113 |
| 6e04f24a-a4ca-4e84-b3b3-7deba0b9cad0 | BUPivacaine HCl 0.75 % in 2 ML Injection [PSN] · 2 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % per 2 ML Injection [SY] · bupivacaine HCl 15 MG per 2 ML Injection [SY] | 4 | 2 | 20200318 | |
| 493569d1-291b-4d89-aa0f-17474d90aa09 | BUPivacaine HCl 0.75 % in 2 ML Injection [PSN] · 2 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % per 2 ML Injection [SY] · bupivacaine HCl 15 MG per 2 ML Injection [SY] | 4 | 1 | General Surgery Kit | 20120925 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 02a845c3-4521-4926-e397-25ab536e7cf6 | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION and BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION and BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE injection, for infiltration, perineural, caudal, or ep | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260309 |
| ffecf450-1f01-4721-8e10-251385852612 | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972 | Eugia US LLC | EUGIA PHARMA SPECIALITIES LIMITED | 20250529 |
| 2dc693df-3218-4a90-b3f7-21e80966a851 | Bupivacaine Hydrochloride in Dextrose Injection, USP STERILE HYPERBARIC SOLUTION FOR SPINAL ANESTHESIA Rx only | Huons Co., Ltd. | 20241120 |
| 27c42bab-2a96-4aca-8fec-e778e2ca8134 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20161018 | |
| 265665e6-f527-4746-af8d-38ba25110b19 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20161011 | |
| 0316eedf-e8c1-483a-8d5a-e1bc1282ead5 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20160929 | |
| 00eb9611-3173-49d2-a81f-164b9244fb87 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20160928 | |
| 1c48aa77-0021-4628-9def-7f9e4c7bbb7a | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20160802 | |
| 1c636622-85e2-4455-a20f-ce0102e806a6 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20160427 | |
| 21283ec3-f1d0-4a35-80d8-f6fc5d30014d | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20160427 | |
| 11b2f885-b837-455c-8d77-0b38e14e35c3 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20150930 | |
| 0d8e930c-9709-4540-bde4-8e7039ce3606 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | 20150528 | |
| 0222f7ec-86ae-474d-ae9a-8ca1b98938a3 | Smiths Medical ASD, Inc. | Hospira, Inc. | 3M Company | 20150312 | |
| 272f30af-1f4a-406b-a23a-0d955ed6a0bb | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | 3M Company | 20140827 | |
| 27cb8ee8-5cbf-4c43-97f0-5c8c38fd2f64 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20140303 | |
| 13cb130f-ef0b-4aa6-8fce-4b1f5de922b3 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20131119 | |
| 09abf090-af04-4381-963d-c88b93c82a21 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20130913 | |
| 04ed52f2-bd25-413c-9791-053440bd8a85 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20130314 | |
| 09156429-0163-4819-bfb0-19b412e905cb | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20121203 | |
| 005bfa1f-b9fd-4d63-a926-515d341667dd | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20121128 | |
| 1c700cc5-f3c0-4398-a5cc-12a651996b67 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20121127 | |
| 2708b5c7-fc57-48af-ab23-ff432c8644eb | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20121023 | |
| 16bdb142-7760-4603-93ec-ae57125cdce2 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20121001 | |
| 167936cf-f527-442f-95a4-a76ad2f9f930 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120917 | |
| 15af6924-29ca-4efc-84f1-7f584db5a86b | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120820 | |
| 1b822e60-ce74-4117-91a3-6b536f2d3a00 | Smiths Medical ASD, Inc. | Hospira, Inc. | 20120807 | |
| 2228d7fe-9788-4a25-b09d-6a7b49cf7b93 | National Council for Prescription Drug Programs | 20120724 | |
| 1e956e6e-4d80-44d4-985b-227b94eea277 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120723 | |
| 27049fe9-8144-486e-b54a-66ec5bdef34e | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120717 | |
| 177552ba-bd25-4111-9c2a-d424c9a9e63e | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120626 | |
| 10161af7-527c-426e-ac8e-c43e4736f2c1 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120625 | |
| 250644e0-94b7-4da2-821a-50f66b54eb35 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120621 | |
| 1643ed50-7c75-4df9-bffb-f0353c97e3c2 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120620 | |
| 213ec9ed-b3b2-4c00-b837-9d4f2a185079 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120618 | |
| 2f88600e-4b76-43dd-8ded-a454b6ed8a0e | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120612 | |
| 251e7648-292b-466e-aea0-da484dd7f781 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120521 | |
| 27a82cef-a75a-4f41-97a1-023f7ba04fc0 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120409 | |
| 1e1ede8b-30a8-4892-bf7b-a4e1ed1e59f3 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120404 | |
| 0d595be4-2a8d-46dd-b230-e5942e3a34b2 | Smiths Medical ASD, Inc. | Hospira, Inc. | 20120301 | |
| 07a6ca28-7a8b-4527-bac6-aa0e72f1ce35 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120301 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N01BB | Amides | ATC1-4 | bupivacaine | |
| FDASPL | D000577 | Amides | CHEM | has_chemical_structure | bupivacaine |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | bupivacaine |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine |
| MEDRT | D002045 | Bupivacaine | CHEM | has_ingredient | bupivacaine |
| MEDRT | D002045 | Bupivacaine | CHEM | has_ingredient | bupivacaine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bupivacaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bupivacaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | bupivacaine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | bupivacaine hydrochloride |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | bupivacaine |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | bupivacaine hydrochloride |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | bupivacaine |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | bupivacaine hydrochloride |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | bupivacaine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | bupivacaine hydrochloride |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | bupivacaine |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | bupivacaine hydrochloride |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine hydrochloride |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 7.5 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | QUANTITY | 2 ML |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA071810 |
| CODES | ANDA | ANDA209087 |
| CODES | ANDA | ANDA212822 |
| CODES | VUID | 4004273 |
| CODES | VUID | 4004279 |
| CODES | VUID | 4044090 |
| NAMES | Prescribable Synonym | BUPivacaine HCl 0.75 % in 2 ML Injection |
| NAMES | Tallman Synonym | 2 ML BUPivacaine hydrochloride 7.5 MG/ML Injection |
| NAMES | Tallman Synonym | BUPivacaine HCl 0.75 % per 2 ML Injection |
| NAMES | Tallman Synonym | BUPivacaine HCl 15 MG per 2 ML Injection |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |